|
May 7
|
Avid Bioservices to Participate at Upcoming Investor Conferences
|
|
May 3
|
How Novo-Catalent Deal Affects Halozyme (HALO)?
|
|
Apr 30
|
Q3 2024 Avid Bioservices Inc Earnings Call
|
|
Apr 30
|
Avid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
|
|
Apr 24
|
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
|
|
Mar 20
|
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
|
|
Mar 11
|
Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results
|
|
Mar 7
|
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
|
|
Mar 6
|
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
|
|
Mar 6
|
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
|
|
Jan 30
|
Avid Bioservices (CDMO) Declined in 2023
|
|
Jan 12
|
Insider Stock Buying Reaches US$527.5k On Avid Bioservices
|
|
Dec 19
|
Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc
|
|
Dec 8
|
Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript
|
|
Dec 7
|
Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges
|
|
Dec 7
|
Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
|
|
Dec 7
|
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
|
|
Dec 1
|
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
|
|
Nov 30
|
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
|
|
Nov 28
|
Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
|